Invasive cervical cancer risk among HIV-infected women is a function of CD4 count and screening
- PMID: 24135779
- PMCID: PMC5534165
- DOI: 10.1097/QAI.0b013e31829cb7c3
Invasive cervical cancer risk among HIV-infected women is a function of CD4 count and screening
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Comment on
-
Is the level of proof of the North American multicohort collaboration prospective study sufficient to conclude that incidence of invasive cervical cancer is higher in HIV-infected women?J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):e163-4. doi: 10.1097/QAI.0b013e31829cb7ab. J Acquir Immune Defic Syndr. 2013. PMID: 24135780 No abstract available.
References
-
- Nazac A, Fridmann S, Boufassa F. Is the level of proof of the North American multicohort collaboration prospective study sufficient to conclude that incidence of invasive cervical cancer is higher in HIV–infected women? J Acquir Immune Defic Syndr. 2013;63:e163. - PubMed
-
- Abraham AG, Strickler HD, Jing Y, et al. for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA Invasive cervical cancer risk among HIV-infected women: a North American multi-cohort collaboration prospective study. J Acquir Immune Defic Syndr. 2012 Dec 18; [Epub ahead of print] - PubMed
-
- Harris TG, Burk RD, Palefsky JM, et al. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA. 2005;293:1471–1476. - PubMed
-
- Strickler HD, Palefsky JM, Shah KV, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst. 2003;95:1062–1071. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials